PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: RNCOS E-Services (P) Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Fast Developing mAb Market Poised to Hit 13.35% Growth - The future of monoclonal antibodies (mAb) seems healthy as the market is expected to grow at a CAGR of 13.35% till 2011, says RNCOS
Fast Developing mAb Market Poised to Hit 13.35% Growth

 

NewswireToday - /newswire/ - Delhi, New Delhi, India, 2008/07/16 - The future of monoclonal antibodies (mAb) seems healthy as the market is expected to grow at a CAGR of 13.35% till 2011, says RNCOS.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

A new research report, “Global Protein Therapeutics Market Analysis”, by RNCOS reveals that the monoclonal antibodies (mAb) market is expected to grow at a CAGR of 13.35% through 2011.

As per the report, mAbs have shorter clinical trial period and faster development timeline in comparison to other drugs that ensures high success rate in development and launching of a mAb on the market. In 2006, about 17 therapeutic mAbs were available in the US market with over 40 new mAb-based therapies in Phase II or Phase III, or earlier stages of clinical development. On the basis of past approval rates, it is expected that 11 mAb products, currently in the pipeline, will be approved by the US Food and Drug Administration. Thus, the number of mAbs will be double the number of present mAbs and this will also lead to a radical rise in revenue generation.

The report identifies the rising number of AIDS and cancer patients as a major future driver for mAb market. The gradually ageing populations in developed as well as developing countries are leading to a rise in the number of new cancer cases, which are expected to rise from 10 Million in 2000 to 15 Million in 2020. Also, the ability to prevent spreading of disease-inducing target cells without damaging healthy cells in the adjacent tissues distinguishes mAbs from other therapies and acts as a key driver for the market. mAb drugs attack specific antigens within cells, tissues and organs without any off-target effects, and thereby have minimum side effects. Thus, due to this feature, mAbs are commercially feasible and successfully used in clinical applications.

The RNCOS research report forecasts that AIIDS (Immune and inflammatory Disorders) and Oncology treatments, at 37% and 47% respectively, will account for the maximum share in the mAb market by 2011.

“Global Protein Therapeutics Market Analysis” provides extensive research and objective analysis on the global protein therapeutics industry. It provides detailed overview of various protein therapeutics used for disease prevention, drivers, market size, key geographical markets, major areas of application, opportunities and challenges critical for the success of the industry.

About RNCOS
RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of industry experts who analyze data collected from credible sources. They provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: RNCOS E-Services (P) Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Fast Developing mAb Market Poised to Hit 13.35% Growth

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Shushmul Maheshwari 
+91 12 04224700 press[.]rncos.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any RNCOS E-Services (P) Ltd securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From RNCOS E-Services (P) Ltd / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Sustainable Alternatives to Polyvinylidene Chloride-coated Films Create Growth Opportunities & Transform the Food Packaging Markets in Western Europe
RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan Has Developed A Way to Engineer Glycan Complexes Clusters of Sugar Chains
The Clinicians of Longs Peak Emergency Physicians Join US Acute Care Solutions
Frost & Sullivan Recognizes BroadReach for Improving the Health and Wellbeing of Underserved Populations
Silver Spring Emergency Physicians Join US Acute Care Solutions
Stress Light Therapy Launches Crowd-Funded Campaign on Indiegogo.com
The Float Space - Brisbane's First Float and Cryo Therapy Centre to Open This November
Thought Leaders Across the Healthcare Spectrum to Participate in Industry-Wide Survey
Frost & Sullivan Names Optum 2016 North America Company of the Year for Population Health Management
R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform
GE to Invest €150 Million in Biopharmaceutical Manufacturing Campus in Cork, Ireland, and Establish Advanced Manufacturing Training Centre At NIBRT
Moriarty Physical Therapy of the Hudson Valley Expands with New Office in Lagrange, NY
Ultimate Medical Group Announces A New Regenerative Medicine Division
Dr. Amir Hanna Introduces New Medical Innovation Taking the Pain Out of Physical Therapy
Samitivej Children’s Hospital Transforms its Sukhumvit Campus

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Triggr & Bloom

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)